SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001225208-19-015851
Filing Date
2019-12-16
Accepted
2019-12-16 16:40:43
Documents
1
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 doc3a.html 3/A  
1 doc3a.xml 3/A 3849
  Complete submission text file 0001225208-19-015851.txt   5187
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Wengel Kathryn E (Reporting) CIK: 0001745955 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-03215 | Film No.: 191287679